Catheter Precision Inc (AMEX: VTAK) open the trading on Tuesday, with great promise as it jumped 7.89% to $0.45, before settling in for the price of $0.42 at the close. Taking a more long-term approach, VTAK posted a 52-week range of $0.31-$8.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 569.59%. Meanwhile, its Annual Earning per share during the time was 66.41%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 93.15%. This publicly-traded company’s shares outstanding now amounts to $8.00 million, simultaneously with a float of $7.83 million. The organization now has a market capitalization sitting at $3.89 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4632, while the 200-day Moving Average is $2.5981.
Catheter Precision Inc (VTAK) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. Catheter Precision Inc’s current insider ownership accounts for 2.18%, in contrast to 2.02% institutional ownership. According to the most recent insider trade that took place on Jan 23 ’24, this organization’s Executive Chairman and CEO bought 9,528 shares at the rate of 0.60, making the entire transaction reach 5,694 in total value, affecting insider ownership by 329,856. Preceding that transaction, on Jan 22 ’24, Company’s Executive Chairman and CEO bought 9,528 for 0.43, making the whole transaction’s value amount to 4,092. This particular insider is now the holder of 320,328 in total.
Catheter Precision Inc (VTAK) Earnings and Revenue Records
Catheter Precision Inc’s EPS increase for this current 12-month fiscal period is 93.15% and is forecasted to reach -6.30 in the upcoming year.
Catheter Precision Inc (AMEX: VTAK) Trading Performance Indicators
Let’s observe the current performance indicators for Catheter Precision Inc (VTAK). It’s Quick Ratio in the last reported quarter now stands at 0.65. The Stock has managed to achieve an average true range (ATR) of 0.05. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.74.
In the same vein, VTAK’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -12.13, a figure that is expected to reach -2.00 in the next quarter, and analysts are predicting that it will be -6.30 at the market close of one year from today.
Technical Analysis of Catheter Precision Inc (VTAK)
[Catheter Precision Inc, VTAK] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 77.69% While, its Average True Range was 0.0488.
Raw Stochastic average of Catheter Precision Inc (VTAK) in the period of the previous 100 days is set at 6.42%, which indicates a major fall in contrast to 75.47% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 82.34% that was lower than 220.23% volatility it exhibited in the past 100-days period.
